New medical knowledge and technology are advancing more quickly than most physicians can keep up with and utilize wisely.  This series of lectures allows physicians to improve techniques involved in the diagnosis and management of disease often seen by Internal Medicine physicians.

OBJECTIVES: Upon completion of this activity, the participant should be able to:

1.   Evaluate the efficacy and applicability of advanced neuromodulation techniques like DBS, HIFU, and TAPS when encountering patients with movement disorders unresponsive to traditional pharmacotherapy so that these options can be    appropriately incorporated into treatment plans.

2.   Obtain a comprehensive history and targeted examination in the clinical evaluation of patients presenting with movement disorders, with sufficient detail to make an informed decision about the feasibility and appropriateness of neuromodulation options.

3.   Counsel patients and caregivers about the pros, cons, and expectations of advanced neuromodulation techniques when discussing treatment options for movement disorders to improve patient understanding and compliance, thereby enhancing the overall quality of care and treatment outcomes.

FACULTY DISCLOSURE: Mazen Elkurd, DO is a consultant and speaker for Abbott Laboratories and was a consultant for Supernus Pharmaceuticals and Kyowa Kirin.

PLANNER DISCLOSURE: Michael Emmett, MD, Byron Cryer, MD, and Randall Rosenblatt, MD have no relevant financial relationship(s) to disclose with companies whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients.

All relevant financial relationships have been mitigated.

ACCREDITATION: The A. Webb Roberts Center for Continuing Medical Education of Baylor Scott & White Health is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

DESIGNATION: The A. Webb Roberts Center for Continuing Medical Education of Baylor Scott & White Health designates this live activity for a maximum of 1.0 AMA PRA Category 1 Credit™.  Physicians should claim only the credit commensurate with the extent of their participation in the activity.

ABIM MOC: Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 1.0 MOC points in the American Board of Internal Medicine’s (ABIM) Maintenance of Certification (MOC) program. It is the CME activity provider’s responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit.
 

For information, please contact Angie Snorgrass at Angie.Snorgrass@bswhealth.org